“Pharmacokinetics of Minocycline Foam FMX103 in Subjects With Moderate-to-Severe Facial Papulopustular Rosacea Under Maximum-Use Conditions: Results of a Phase 1 Study”, J of Skin, vol. 3, no. 2, p. 162, Mar. 2019, doi: 10.25251/skin.3.2.2.